Innate Pharma S.A. ADS - relatórios financeiros trimestrais (NASDAQ:IPHA) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Market Capitalization 160.26 M
Employee 163
Founded 1999
CEO N/A
Website www.innate-pharma.com
Headquarter France
FIGI BBG009ZCBVG7
Industry Technology

160.26 M Market capitalization

Notícias

Innate Pharma S.A. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IPHA) 2026-03-27

Innate Pharma S.A. (IPHA) Q4 2025 Earnings Call Transcript

Innate Pharma registra redução de custos e foco estratégico no 4º tri de 2025

Innate Pharma S.A. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:IPHA) 2025-11-15

Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - BigBear.ai Hldgs (NYSE:BBAI), Aspire Biopharma Hldgs (NASDAQ:ASBP)

Innate Pharma (IPHA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Edwards Lifesciences (NYSE:EW), Brookfield Infr Partners (NYSE:BIP)

Innate Pharma S.A. (IPHA) Analyst/Investor Day Transcript

Innate Pharma S.A. (IPHA) Analyst/Investor Day - Slideshow (NASDAQ:IPHA) 2025-10-28

Innate Pharma S.A. (IPHA) Q2 2025 Earnings Call Transcript

Innate Pharma stock initiated with Buy rating at BTIG on cancer therapy potential

Innate Pharma stock surges on promising preclinical data